Erythrocyte Indices in Patients with Preeclampsia

Amaç: Bu çalışmanın amacı preeklampsi tanısı konmuş hastalarda eritrosit indekslerini araştırmaktır. Gereç ve Yöntemler: Bu çalışmaya 102 preeklampsi (49 hafif ve 53 şiddetli preeklampsi olmak üzere) ve 98 kontrol hastası dahil edilmiştir. Tüm çalışma grubunda eritrosit indeksleri olan ortalama korpuskular hacim (MCV), ortalama korpuskular hemoglobin (MCH), ortalama korpuskular hemoglobin konsantrasyonu (MCHC), eritrosit sayımı ve eritrosit dağılım genişliği değerleri otomatik kan sayım cihazı ile ölçüldü Bulgular: Preeklampsi grubunda, medyan RDW %15 (13,8-16,57), ortalama MCV değeri 80,42±7,86 (fL), ortalama MCHC değeri 33,66±1,71 (g/dL) ve kontrol grubunda medyan RDW %13,9 (13-15,6), ortalama MCV değeri 83,88±2,31 (fL), ortalama MCHC değeri 33,09±1,48 (g/dL) idi (sırasıyla p0,05). Preeklampsi grubunda subgroup analizi yapıldığında, hafif preeklampsi grubuna göre, ciddi preeklampsi grubunda artmış RDW değerleri (% 15,4 (13,9-17,45) vs %14,3 (13,7-15,7), p=0,031), azalmış MCV değerleri (78,81±7,91 (fL) vs 82,16±7,43 (fL), p=0,03), artmış RBC değerleri (4,16 (3,79-4,85)x(1012/L) vs 3,82 (3,45-4,34)x(1012/L), (p=0,006) saptandı. Preeklampsi ve kontrol grubu hastalarının Receiver operatör karakteristik (ROK) analizi sonuçlarına göre eritrosit sayımı ve eritrosit dağılım genişliğinin hastalığı tespit etmede yüksek prediktif değerleri saptandı (p

Preeklamptik Hastalarda Eritrosit İndeksleri

Objective: The purpose of study was to investigate erythrocyte indices in patients with preeclampsia. Materials and Methods: The study population consisted of 102 patients with preeclampsia (49 mild, 53 severe preeclampsia) and 98 control pregnant patients. For the entire study population, red blood cell indices, including baseline mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), and red blood cell (RBC) were measured by using an automatic blood counter.Results: In the preeclampsia group, the median RDW was 15% (13.8-16.57), whereas in the control group it was 13.9% (13-15.6) (p<0.01). On the other hand, the mean MCV value was 80.42±7.86 (fL) in preeclampsia group and 83.88±2.31 (fL) in control group (p=0.003). Besides, the mean MCHC value was 33.66±1.71 (g/dL) in preeclampsia group and 33.09±1.48 (g/dL) in control group (p=0.012). However MCH and RBC values were not statistically different between the groups. (p>0.05) Moreover, subgroup analysis revealed that RDW levels were significantly increased in preeclampsia subjects than in mild preeclampsia patients (15.4% (13.9-17.45) vs 14.3% (13.7-15.7), p=0.031), MCV levels were decreased (78.81±7.91 (fL) vs 82.16± 7.43 (fL), p=0.03), RBC values were increased (4.16 (3.79-4.85)x(1012/L) vs 3.82 (3.454.34)x(1012/L), (p=0.006)) in patients with severe preeclampsia when compared to the patients with mild preeclampsia. In the receiver operator characteristic (ROC) analysis of subjects with and without preeclampsia, RDW and MCV showed high predictive values (p<0.01). Besides, in ROC analysis of preeclampsia patients with different severities, RDW and RBC showed the ideal predictive values (p=0.006, p=0.031, respectively).Conclusion: Our study results revealed that among the red blood cell indices, only increased RDW values were associated with both the presence and the severity of preeclampsia.

___

  • Roberts CL, Algert CS, Morris JM, Ford JB, Henderson-Smart DJ. Hypertensive disorders in pregnancy: a population-based study. Med J Aust 2005; 182: 332-5.
  • North RA, Taylor RS, Schellenberg JC. Evaluation of a definition of pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 767-73.
  • Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-4.
  • Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-7.
  • Gezer C, Ekin A, Özeren M, Taner CE, Avcı ME, Doğan A. Erken ve geç preeklampside birinci trimester inflamasyon belirteçlerinin yeri. Perinatal Journal 2014; 22: 128-32.
  • Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4: 397-413.
  • Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med 2007; 28: 192-209.
  • Bessman JD, Gilmer PR Jr, Gardner FH . Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983; 80: 322-6.
  • Sultana GS, Haque SA, Sultana T, Rahman Q, Ahmed AN. Role of red cell distribution width (RDW) in the detection of iron deficiency anemia in pregnancy within the first 20 weeks of gestation. Bangladesh Med Res Counc Bull 2011; 37: 102-5.
  • Tanindi A, Topal FE, Topal F, Celik B. Red cell distribution width in patients with prehypertension and hypertension. Blood Press 2012; 21: 177-81.
  • Montagnana M, Cervellin G, Meschi T, Lippi G. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med 2011; 50: 635-41.
  • Liu DS, Jin Y, Ma SG, Bai F, Xu W. The ratio of red cell distribution width to mean corpuscular volume in patients with diabetic ketoacidosis. Clin Lab 2013; 59: 1099-104.
  • ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77: 67-75.
  • Abdullahi H, Osman A, Rayis DA, Gasim GI, Imam AM, Adam I. Red blood cell distribution width is not correlated with preeclampsia among pregnant Sudanese women. Diag Pathol 2014; 9: 29.
  • Kurt RK, Aras Z, Silfeler DB, Kunt C, Islimye M, Kosar O. Relationship of red cell distribution width with the presence and severity of preeclampsia. Clin Appl Thromb Hemost 2015; 21: 128-31.
  • Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB, et al. Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci 2010; 65: 258-65.
  • Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure:prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 2009; 158: 659-66.
  • Kim J, Kim YD, Song TJ, Park JH, Lee HS, Nam CM, et al. Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction. Thromb Haemost 2012; 108: 349-56.
  • Jo YH, Kim K, Lee JH, Kang C, Kim T, Park HM, et al. Red cell distribution width is a prognostic factor in severe sepsis and septic shock. Am J Emerg Med 2013; 31: 545-8.
  • Seyhan EC, Ozgül MA, Tutar N, Omür I, Uysal A,Altin S. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD 2013; 10: 416-24.
  • Lou Y, Wang M, Mao W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLOS ONE 2012; 7: 37644.
  • Yeşil A, Senateş E, Bayoğlu IV, Erdem ED, Demirtunç R, Kurdaş Övünç AO. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut Liver 2011; 5: 460-7.
  • Grant BJ, Kudalkar DP, Muti P, McCann SE, Trevisan M, Freudenheim JL, et al. Relation between lung function and RBC distribution width in a population-based study. Chest 2003; 124: 494-500.
  • Koma Y, Onishi A, Matsuoka H, Oda N, Yokota N, Matsumoto Y, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS ONE 2013; 8: 80240.
  • Al-Najjar Y, Goode KM, Zhang J, Cleland JG, Clark AL. Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail 2009; 11: 1155-62.
  • Isik T, Kurt M, Ayhan E, Tanboga IH, Ergelen M, Uyarel H. The impact of admission red cell distribution width on the development of poor myocardial perfusion after primary percutaneous intervention. Atherosclerosis 2012; 224: 143-9.
  • Ozcan F, Turak O, Durak A, Işleyen A, Uçar F, Giniş Z, et al. Red cell distribution width and inflammation in patients with non-dipper hypertension. Blood Press 2013; 22: 80-5.
  • Shehata HA, Ali MM, Evans-Jones JC, Upton GJ, Manyonda IT. Red cell distribution width (RDW) changes in pregnancy. Int J Gynaecol Obstet 1998; 62: 43-6.
  • Rebelo I, Carvalho-Guerra F, Preira-Leite L, Qintanilha A. Comparative study of lactoferrin and other blood markers of inflammatory stress between preeclamptic and normal pregnancies. Eur J Obstet Gynecol Reprod Biol 1996; 64: 167-73.
  • Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW. A new animal model for human preeclampsia: ultralow- dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994; 171: 158-64.
  • Troeger C, Holzgreve W, Ladewig A, Zhong XY, Hahn S. Examination of maternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and preeclamptic pregnancies. Fetal Diagn Ther 2006; 21: 156-60.
  • Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 2005; 20: 83-90.
  • Catarino C, Rebelo I, Belo L, Rocha-Pereira P, Rocha S, Bayer Castro E, et al. Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damage. J Perinat Med 2009; 37: 19-27.
  • Santos-Silva A, Castro EM, Teixeira NA, Guerra FC, Quintanilha A. Erythrocyte membrane band 3 profile imposed by cellular aging, by activated neutrophils and by neutrophilic elastase. Clin Chim Acta 1998; 275: 185-96.
  • Weiss DJ, Aird B, Murtaugh MP. Neutrophil-induced immunoglobulin binding to erythrocytes involves proteolytic and oxidative injury. J Leukoc Biol 1992; 51: 19-23.
  • Brovelli A, Castellana MA, Minetti G, Piccinini G, Seppi C, De Renzis MR, et al. Conformational changes and oxidation of membrane proteins in senescent human erythrocytes. Adv Exp Med Biol 1991; 307: 59-73.
  • Hershkovitz R, Ohel I, Sheizaf B, Nathan I, Erez O, Sheiner E, et al. Erythropoietin concentration among patients with and without preeclampsia. Arch Gynecol Obstet 2005; 273: 140-3.
  • Chanarin I, Mcfadyen IR, Kyle R. The physiological macrocytosis of pregnancy. Br J Obstet Gynecol 1977; 84: 504-8.
  • Heilmann L, Rath W, Pollow K. Hemorheological changes in women with severe preeclampsia. Clin Hemorheol Microcirc 2004; 31: 49-58.
  • Makuyana D, Mahomed K,Shukusho FD, Majoka F. Liver and kidney function tests in normal and pre-eclamptic gestation--a comparison with non-gestational reference values. Cent Afr J Med 2002; 48: 55-9.
  • Douglas SW, Adamson JW. The anemia of chronic disorders: studies of marrow regulation and iron metabolism. Blood 1975; 45: 55-65.
  • Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi AM, et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 2005; 118: 1288.
  • Yüce MA, Sevinç E, Pekdemir S,Yardım T. Preeklampside serum demir ve ferritin düzeyleri. Trakya Üniversitesi Tıp Fakültesi Dergisi 1996; 13: 24-9.